Tumor hypoxia is typically presented in the central region of solid tumors, which is mainly
caused by an inadequate blood flow and oxygen supply. In the conventional treatment of …

Long-term tumor hypoxia has always been a huge obstacle for oxygen dependent
photodynamic therapy (PDT) and anticancer drug chemotherapy. Herein, a hollow …

Combining the internal force-driven chemodynamic therapy (CDT) and the external energy-
triggered photodynamic therapy (PDT) holds great promise to achieve an advanced …

Hypoxia is one of the hallmarks of solid tumor, which heavily restricts the clinical cancer
therapy treatments, especially for the oxygen (O 2)-dependent photodynamic therapy (PDT) …

Tumor hypoxia compromises the therapeutic efficiency of photodynamic therapy (PDT) as
the local oxygen concentration plays an important role in the generation of cytotoxic singlet …

Oxygen (O2) plays a critical role during photodynamic therapy (PDT), however, hypoxia is
quite common in most solid tumors, which limits the PDT efficacy and promotes the tumor …

Inorganic biophotocatalysts with suitable size are greatly attractive in photodynamic therapy
(PDT) with enhanced permeability and retention effect and the capability to produce reactive …

Conventional oxygen‐dependent photodynamic therapy (PDT) has faced severe challenges
because of the non‐specificity of most available photosensitizers (PSs) and the hypoxic …

This paper reported on a two-photon excited nanocomposite FCRH to overcome tumor
hypoxia for enhanced photodynamic therapy (PDT). Through modified by ruthenium (Ⅱ) …

Improving the supply of O 2 and the circulation lifetime of photosensitizers for photodynamic
therapy (PDT) in vivo would be a promising approach to eliminate hypoxic tumors. Herein …